Head of Genomic Sequencing
William Biggs, PhD is Head of Genomic Sequencing for HLI. He and his team are building the largest genomic sequencing facility in the world which currently has two Illumina HiSeq XTen sequencing systems, growing to a total of 40 sequencers. He comes to the company from the Clinical Research Sequencing Platform (CRSP) at the Broad Institute of MIT and Harvard where he was the Director of Clinical Sequencing. In his role at CRSP he and his team supported pivotal clinical diagnostic, research and trials efforts to identify applications for deep sequencing in the process of medical decision-making. He was also responsible for assisting in the assembly of an evidence base required for broad-based reimbursement and utilization of deep sequencing in patient management. Prior to joining the Broad Institute Dr. Biggs was the Director of Genetics and Genomics at Aviir Diagnostic Laboratories. Prior joining Aviir, Dr. Biggs as Director of Technical Operations, was a member of the founding team at Affymetrix Clinical Service Laboratories. Dr. Biggs obtained his Ph.D. in Biological Chemistry from UCLA in 1994 and has extensive experience in elucidating the roles of genetics, signal transduction and transcriptional regulation during the initiation of progression of disease gained during studies conducted at The Salk Institute, The Ludwig Institute for Cancer Research, and Ambit Biosciences.